Moderna
MRNA
$153.58
Share price
4.16%
Change (1 day)
-13.03%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Earnings for Moderna (MRNA)
Earnings in 2022 (TTM): $9.60 B
According to Moderna 's latest financial reports the company's current earnings (TTM) are $9.60 B. In 2021 the company made an earning of $13.30 B an increase over its 2020 earnings that were of -$0.74 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Moderna from 2018 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | $9.60 B | -27.81% |
| 2021 | $13.30 B | -1910.85% |
| 2020 | -$0.74 B | 44.58% |
| 2019 | -$0.51 B | 28.76% |
| 2018 | -$0.4 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.00 B | 129.08% | 🇺🇸 USA |
 Novartis NVS | $8.37 B | -12.84% | 🇨🇭 Switzerland |
 Merck MRK | $17.40 B | 81.24% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | -$27.96 M | -100.29% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | -$0.12 B | -101.23% | 🇺🇸 USA |
 Athersys ATHX | -$85.03 M | -100.89% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$0.98 B | -110.11% | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | -$0.16 B | -101.64% | 🇺🇸 USA |